Revelation Biosciences (REVB) Institutional Ownership

$2.09
+0.02 (+0.97%)
(As of 04/24/2024 ET)

Institutional Ownership Changes (13F Filings) for Revelation Biosciences (NASDAQ:REVB)

Current
Institutional Ownership
Percentage
12.80%
Number of
Institutional Buyers
(last 12 months)
4
Total
Institutional Inflows
(last 12 months)
$12.71M
Number of
Institutional Sellers
(last 12 months)
0
Get REVB Insider Trade Alerts

Want to know when executives and insiders are buying or selling Revelation Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

REVB Institutional Buying and Selling by Quarter

Revelation Biosciences Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/15/2023Sabby Management LLC403,233$278K0.2%+14.2%6.401%
7/27/2023Virtu Financial LLC66,972$63K0.0%N/A1.107%
5/19/2023Anson Funds Management LP213,509$278K0.0%N/A3.700%
5/16/2023Altium Capital Management LP37,198$48K0.0%N/A0.644%
5/12/2022Monashee Investment Management LLC817,562$932K0.3%N/A5.420%
(Data available from 1/1/2016 forward)

REVB Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of REVB shares?

During the previous two years, the following institutional investors and hedge funds held shares of Revelation Biosciences shares: Monashee Investment Management LLC ($932K), Sabby Management LLC ($278K), Anson Funds Management LP ($278K), and Virtu Financial LLC ($63K), Altium Capital Management LP ($48K).Learn more on REVB's institutional investors.

What percentage of Revelation Biosciences stock is owned by institutional investors?

12.80% of Revelation Biosciences stock is owned by institutional investors. Learn more on REVB's institutional investor holdings.

Which institutional investors have been buying Revelation Biosciences stock?

The following institutional investors have purchased Revelation Biosciences stock in the last 24 months: Monashee Investment Management LLC ($817.56K), Anson Funds Management LP ($213.51K), Virtu Financial LLC ($66.97K), Sabby Management LLC ($50K), and Altium Capital Management LP ($37.20K).

How much institutional buying is happening at Revelation Biosciences?

Institutional investors have bought a total of 1,185,241 shares in the last 24 months. This purchase volume represents approximately $991.34M in transactions.


This page (NASDAQ:REVB) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners